Francois-Xavier Mahon, MD, PhD of University of Bordeaux, presents a press briefing on Cessation of Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid Leukemia Patients with Deep Molecular Response: Results of the Euro-Ski Trial at the 58th ASH Annual Meeting in San Diego, CA.
Tyrosine Kinase Inhibitors Treatment in CML Patients with Deep Molecular Response
